ENTITY
New Horizon Health

New Horizon Health (6YZ GR)

61
Analysis
Health Care • China
New Horizon Health Limited is a China-based investment holding company focused on early cancer screening and in-home testing, with an emphasis on colorectal, gastric, and cervical cancers. Its key products include ColoClear and Pupu Tube. The company was founded in 2015 and is headquartered in Hangzhou, China.
more
bullish•New Horizon Health
•05 Feb 2021 13:45

New Horizon Health (诺辉偄康) IPO: Room to Fly

We think there is substantial upside from the high end. The line-up of cornerstone investors is strong. We are seeing strong demand from...

Logo
2.1k Views
Share
bullish•New Horizon Health
•04 Feb 2021 22:20

New Horizon Health IPO: Valuation Insights

New Horizon will raise gross proceeds of $244 million at the mid-point of the proposed IPO price range of HK$22.70-26.66. We would participate in...

Logo
1.2k Views
Share
bullish•New Horizon Health
•03 Feb 2021 02:43

New Horizon Health IPO: PHIP Updates

New Horizon Health operates in the Chinese colorectal cancer screening market. The company has filed for an IPO on the HKEX and plans to raise...

Share
bullish•New Horizon Health
•02 Feb 2021 23:06

New Horizon Health IPO: Poised for Growth

New Horizon is set to launch a $300m HK IPO on Thursday. The PHIP which disclose the 9M20 results and the all-important NMPA approval for ColoClear...

Logo
386 Views
Share
bullish•Kuaishou Technology
•24 Jan 2021 09:14

ECM Weekly (24 January 2021) - Kuaishou, New Horizon Health, Indigo Paints, Home First Fin, IRFC

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x